In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus

Medical Mycology

Volumn 48, Issue 1, 2010, Pages 97-102

  Alastruey Izquierdo, Ana ^a   Cuesta, Isabel ^a   Houbraken, Jos ^b   Cuenca Estrella, Manuel ^a   Monzón, Araceli ^a   Rodriguez Tudela, Juan L ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

Author keywords

Antifungal susceptibility profile; Aspergillus calidoustus; Beta tubulin

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; RAVUCONAZOLE; RIBOSOME DNA; TERBINAFINE; TUBULIN; VORICONAZOLE; FUNGAL DNA; FUNGAL PROTEIN; RIBOSOMAL SPACER DNA;

ARTICLE; ASPERGILLUS; ASPERGILLUS CALIDOUSTUS; ASPERGILLUS PSEUDODEFLECTUS; CONTROLLED STUDY; DRUG SENSITIVITY; GENE SEQUENCE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; ASPERGILLOSIS; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; SPAIN;

ASPERGILLUS; ASPERGILLUS PSEUDODEFLECTUS;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; DNA, FUNGAL; DNA, RIBOSOMAL; DNA, RIBOSOMAL SPACER; FUNGAL PROTEINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SPAIN; TUBULIN;

EID: 74949093153     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780902803040     Document Type: Article

References (27)

1. Houbraken J, Due M, Varga J, et al. Polyphasic taxonomy of Aspergillus section Usti. Stud Mycol 2007; 59: 107-128.
2. Varga J, Houbraken J, Van Der Lee HA, Verweij PE, Samson RA. Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus. Eukaryot Cell 2008; 7: 630-638.
3. Thom C, Raper K. Manual of Aspergilli. Baltimore : 1945.
4. Panackal AA, Imhof A, Hanley EW, Marr KA. Aspergillus ustus infections among transplant recipients. Emerg Infect Dis 2006; 12: 403-408.
5. Pavie J, Lacroix C, Hermoso DG, et al. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin pro phylaxis. J Clin Microbiol 2005; 43: 4902-4904.
6. Saracli MA, Mutlu FM, Yildiran ST, et al. Clustering of invasive Aspergillus ustus eye infections in a tertiary care hospital: a molecular epidemiologic study of an uncommon species. Med Mycol 2007; 45: 377-384.
7. Yildiran ST, Mutlu FM, Saracli MA, et al. Fungal endophthalmitis caused by Aspergillus ustus in a patient following cataract surgery. Med Mycol 2006; 44: 665-669.
8. Gene J, Azon-Masoliver A, Guarro J, et al. Cutaneous infection caused by Aspergillus ustus, an emerging opportunistic fungus in immunosuppressed patients. J Clin Microbiol 2001; 39: 1134-1136.
9. Iwen PC, Rupp ME, Bishop MR, et al. Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantation. J Clin Microbiol 1998; 36: 3713-3717.
10. Verweij PE, van den Bergh MF, Rath PM, et al. Invasive aspergillosis caused by Aspergillus ustus : case report and review. J Clin Microbiol 1999; 37: 1606-1609.
11. Holden DW. DNA mini prep method for Aspergillus fumigatus (and other filamentous fungi). In: Maresca B, Kobayashi GS (eds). Molecular Biology of Pathogenic Fungi, A Laboratory Manual. New York: Telos Press, 1994: 3-4.
12. White TJ, Burns T, Lee S, Taylor J. Amplifi cation and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis M (ed.). PCR Protocols: A Guide to Methods and Applications. San Diego, Academic Press, 1990: 315-322.
13. Balajee SA, Gribskov JL, Hanley E, Nickle D, Marr KA. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell 2005; 4: 625-632.
14. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzon A, Rodriguez-Tudela JL. Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates. Antimicrob Agents Chemother 2007; 51: 748-751.
15. Tudela JLR, Donnelly JP, Arendrup MC, et al. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidiaforming moulds-Subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST). Clinl Microbiol Infect 2008; 14: 982-984.
16. Rodriguez-Tudela JL, Chryssanthou E, Petrikkou E, et al. Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi. J Clin Microbiol 2003; 41: 5236-5237.
17. Petrikkou E, Rodriguez-Tudela JL, Cuenca-Estrella M, et al. Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans. J Clin Microbiol 2001; 39: 1345-1347.
18. Aberkane A, Cuenca-Estrella M, Gomez-Lopez A, et al. Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J Antimicrob Chemother 2002; 50: 719-722.
19. National Committee for Clinical Laboratory Standards. R eference method for broth dilution antifungal susceptibility. Testing of filamentous fungi: Approved Standard Document M38-A. Reference method for broth dilution antifungal susceptibility 2005; 22 (16).
20. Arikan S, Lozano-Chiu M, Paetznick V, Rex JH.. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother 2001; 45: 327-330.
21. Kurtz MB, Heath IB, Marrinan J, et al. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase. Antimicrob Agents Chemother 1994; 38: 1480-1489.
22. de Hoog G, Guarro J, Tan CS, Wintermans RGF, Gene J. Hyphomycetes . In: de Hoog GS, Guarro J (eds), Atlas of Clinical Fungi. Reus, Spain and Utrecht. The Netherlands: Universitat Rovirai Virgili and Central bureau voor Schimmelcultures 1995; 380-1007.
23. Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005; 43: S49-S58.
24. Gomez-Lopez A, Garcia-Effron G, Mellado E, et al. In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. Antimicrob Agents Chemother 2003; 47: 3085-3088.
25. Azzola A, Passweg JR, Habicht JM, et al. Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection. J Clin Microbiol 2004; 42: 4805-4808.
26. Carrizosa J, Levison ME, Lawrence T, Kaye D. Cure of Aspergillus ustus endocarditis on a prosthetic valve. Arch Intern Med 1974; 133: 486-490.
27. Vagefi PA, Cosimi AB, Ginns LC, Kotton CN. Cutaneous A spergillus ustus in a lung transplant recipient: emergence of a new opportunistic fungal pathogen. J Heart Lung Transplant 2008; 27: 131-134.